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Accumulating studies in animals have shown that nanoparticles could cause unusual rapid lung
injury and extrapulmonary toxicity. Whether exposure of workers to nanoparticles may result in
some unexpected damage as seen in animals is still a big concern. We previously reported
ﬁndings regarding a group of patients exposed to nanoparticles and presenting with an unusual
disease. The reported disease was characterized by bilateral chest ﬂuid, pulmonary ﬁbrosis, pleu-
ral granuloma, and multiorgan damage and was highly associated with the nanoparticle exposure.
To strengthen this association, further information on exposure and the disease was collected
and discussed. Our studies show that some kinds of nanomaterials, such as silica nanoparticles
and nanosilicates, may be very toxic and even fatal to occupational workers exposed to them
without any effective personal protective equipment. More research and collaborative efforts on
nanosafety are required in order to prevent and minimize the potential hazards of nanomaterials
to humans and the environment.
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1. INTRODUCTION
With the development and wide use of nanomaterials, concerns and fears have been expressed regarding
potential risks of nanoparticles to worker’s safety, human health, and environment contamination [1]. Due
to their unique physicochemical properties such as extremely small size, large surface area, and functional
coating,nanomaterialsmayexhibitnonclassicbioactivityandinteractwith cellularorsubcellularstructures.
And accumulatingresearchdata using animal or cultured cell modelshaveshownnanoparticlescould cause
unusual rapid lung injury and extrapulmonary toxicity [2, 3]. It is possible theoretically that long-term
exposure to nanoparticles may cause some unexpected damage to humans as seen in animals.
We previously reported ﬁndings regarding a group of patients, who worked at the same workplace
in a print plant for 5–13 months exposing to nanoparticles [4]. These workers presented with dyspnea on
exertionpericardialandpleuraleffusionsandrash with intense itching.The symptomsseenin thesepatients
were similar to those seen in animals exposed to nanoparticles. In addition, considering particle size and
deposition model, the damage in lungs was highly associated with the nanoparticle exposure. To strength
this association, further information on exposure and disease was collected. In this paper, we will discuss
these unusual diseases and their nanoexposure.
2. UNUSUAL DISEASE AND NANOEXPOSURE
Our seven patients, 18–47 years old female workers, were all previously in good health and nonsmokers.
Theywerefoundin almostthesametimeframe withthesamesymptomsofshortnessofbreathandthesame
clinical ﬁndings such as pleural effusion, progressive pulmonary ﬁbrosis, and pleural damage. In addition,
multiorgan damagewas observedincluding disorders of haematotoxicity,cardiotoxicity, hepatotoxicity,and
dermaltoxicity. And a two-year follow-up revealedthat two patients died ofpulmonary failure and ﬁvewere
disabled with severe pulmonary dysfunction.
In the early disease stage [4, 5], the pathological examination showed the effusion of inﬂammatory
cells in tunica mucosa bronchiorum, aggregations of macrophages and inﬂammatory cells, proteinaceous
effusions in the alveolar space, swollen and widened alveolar septums with scattered neutrophil leukocytes,
and pulmonary ﬁbrosis. And pathological study of pleura exhibited ﬁbrinous and inﬂammatory cells,
foreign-body granulomas, and haemorrhage. In the late stage, damage to pulmonary tissue was similar
to but more prominent than that in the early stage. Pulmonary alveoli were partly emphysematous with
aggregations of macrophagesand type II alveolar epithelial cell proliferations, and the alveolar septum was
widened with blood vessel dilatation and congestion. Notably, damage to alveolar epithelial cells, macro-
phages, vascular endothelial cells, and the blood-gas barrier was also observed.
All the patients are characterized with pleural effusions. Some common causes of pleural effusions
are lung infections, tuberculosis, pulmonary embolism, breast cancer, lung cancer, or autoimmune diseases.
However, clinical examinations and long-term follow-up have eliminated the possibility of above diseases
in our patients.
3. EXPOSURE IN THE WORKPLACE
The coating material used in the workplace, an ivory white soft paste (polyacrylic ester stated by the paste
producer), was analyzed by gas chromatography/mass spectrometry (GC/MS), and was found containing
the following components [4]: butanoic acid, butyl ester, N-butyl ether, acetic acid, toluene, di-tert-butyl
peroxide, 1-butanol, acetic acid ethenyl ester, isopropyl alcohol, and ethylene dioxide. Unfortunately, these
patients exhibited none of the signs and symptoms related to these irritant or asphyxiant gases, such as
coughing, eye irritation, dizziness/headaches, drowsiness, nausea, or vomiting. In addition, the powder
componentintherawmaterialsusedintheworkplacewasdeterminedbyinductivelycoupledplasmaatomic
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emission spectrometry (ICP-AES) and was found containing (%): Si 0.016, Ba 0.069, Ca 0.20, Mg 0.051,
Cu 0.0090, Fe 0.098, K 0.015, Na 0.82, Zn 0.0085, and P 0.048 [5, 6].
Nanoparticles found in the patients’ pulmonary tissues and chest effusions were the same raw
materials used by these workers. Element of silica of nanoparticles was identiﬁed in biopsiesand chestﬂuid
byusingtransmissionelectronmicroscopyandenergydispersiveX-rayanalysis.Theywerelargelyfoundin
macrophages(cytoplasm,mitochondria,lysosomes,and nuclei), pulmonary microvascularvessels,vascular
endothelialcells, microlymphatic vessels,andpleural effusions.We alsoobservedsilica nanoparticlesaccu-
mulated in alveolar epithelial cells and pulmonary interstitial tissue but to a less extent [4, 5]. In addition,
nanosilicates, as well as microscale silicates, were also observed in a patient pleural effusion and contained
elements of Si, Ca, Mg, K, Na, Ba, Al, P, S, Cl, and O [5].
Theconcordanceofthecomponentsofpowderin therawmaterialandnanomaterialsin patients’bio-
psies indicated that the powder in the raw material was made of silica nanoparticles and silicates, a mixture
used to obtain some special coating quality, such as abrasive resistant, ﬂame retardant, or adherent. Thus,
a rough sketch can be made of the coatings used at these patients’ workplace: ﬁlters and additives of silica
nanoparticles and nano- and microscale silicates, a ﬁlm-forming polyacrylate agent, and various solvents,
including butanoic acid, butyl ester, acetic acid, and toluene.
4. WHY WERE SILICA NANOPARTICLS AND NANOSILICATES USED TOGETHER IN
THE PRODUCTION OF NANOCOATINGS AND FOUND IN THE COATINGS USED
IN THE WORKPLACE?
Coatings usually have several components of binders, pigments, solvents, ﬁllers, and additives [7]. Fillers
and additives are generally composed of natural or synthetic minerals, such as silicon dioxide, barium sul-
fate, silicates, or a complexmixture of the abovematerials, to produce specialand improved functions, such
as water resistance, transparency, and ﬂame retardation [7, 8]. Due to their small size, large speciﬁcs u r -
face area, and more alkyl groups in different bonding states, silica nanoparticles in coatings can markedly
improve the suspension stability, weatherability, tensile strength, and the washing, infrared, abrasion, heat,
and radiation resistances of a coating and even yield the coating clear at the same time [8, 9]. However,
microsilica can only increase the hardness and abrasion resistance [9]. Similarly, Layered silicates, another
very popular coating nanomaterial ingredient, play an important role as adsorbents, catalysts, and ionic
exchangers in the production of nanocoatings and could greatly increase thermal stability and act as ﬁre
retardants in the form of nanocomposites [10].
Nanosilicates, often characterized by only one dimension in the nanometer range, are a group of
very complex chemical substances in which there is a copolymerization of silicic acid with hydroxides of
other metals drawn from almost the entire periodic table [11], while silicates isolated in our patients con-
tain 13–15 different elements and widely varying O/Si ratios. Their structure consists of layers made up of
two tetrahedrally coordinated silicon atoms fused to an edge-shared octahedral sheet of either aluminum
or magnesium hydroxide. Using layered nanosilicates in nanomaterials, several structural types may be ob-
tained, including intercalated nanocomposites in which polymer chains are sandwiched between silicate
layers and exfoliated nanocomposites in which separated, individual, silicate layers are more or less uni-
formly dispersed in a polymer matrix. These nanocomposites exhibit markedly improved mechanical, ther-
mal, optical, and physicochemical properties compared with pure polymers or conventional (microscale)
composites [10].
Given the beneﬁts of silica nanoparticles and nanosilicates, they are usually utilized concurrently in
varying ratios to each other in the production of nanocomposite coatings. And this may be the very reason
that amorphous silica and silicates in nanoscale were found in the raw materials that these workers exposed
to.
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5. EXPOSURE TO SILICA AND/OR SILICATE RESULTS IN PNEUMOCONIOSIS,
WHAT IF EXPOSURE TO SILICA AND/OR SILICATE IN NANOSCALE?
Occupational exposures to inhaled pathogenic particles and ﬁbers such as silica and silicate have been
associated with the development of lung inﬂammation and occupational disease. These diseases include
silicosis, interstitial ﬁbrosis, industrial bronchitis, small airway disease, emphysema, and vascular diseases
as well as immunologic reactions [12, 13]. Even though amorphous silica appears less toxic than the crys-
talline form, toxicological studies about amorphous silica nanoparticles have exhibited that they increase
reactive oxygen species (ROS) concentrations, reduce glutathione levels, and induce pro-inﬂammatory,
inﬂammatory, and oxidative stress responses both in vivo and in vitro [14, 15]. Amorphous silica nanopar-
ticles can enter cell nuclei where reducing aberrant clusters of topoisomerase I and protein aggregates in
the nucleoplasm [16]. In vitro studies also show that amorphous silica nanoparticles disturb mitochondrial
function and lower cell survival via decreasing cell survival signaling in human neural cells [17]. Further-
more, amorphous nanosilica has been shown to accumulate in the lung, liver, kidney, gut, bone marrow,
and brain in animal experiments and cause multiorgan damage [14].
Exposure to silica and/or silicate results in pneumoconiosis,what if exposure to silica and/or silicate
in nanoscale?Giventhe well-documentedtoxicity ofmicroscalesilica in humansandﬁndingsofamorphous
silica nanoparticles in animals, it is possible that these silica nanoparticles may have been contributed in
part to these patients’ disease and multiorgan damage, whatever they exerted toxicities directly or acted as
carriers. These patients were found multiorgan damage, which may have been related to nanoparticle en-
try into the systematic circulation and multiorgan deposition. These silica nanoparticles in the nuclei may
potentially bind to the DNA phosphate backbone, inﬂuence nuclear integrity, and trigger genotoxicity by
physical-chemical interaction, forming intranuclear protein aggregates, and regulating redoxsensitive tran-
scription factors and DNA-damage responsive signaling, as seen in animal-based nanotoxicological stud-
ies [16–18], and also, these silica nanoparticles in cytoplasm may exert cytotoxicity by increasing reactive
oxygen species and by inducing proinﬂammatory, inﬂammatory, and oxidative stress responses, as seen
both in vivo and in vitro [14, 15].
6. THE POTENTIAL TRANSLOCATION PATHWAYS OF NANOPARTICLES AND
THEIR POTENTIAL DAMAGE
A hypothesis of the potential translocation pathways of nanoparticles and their potential damage was made
as follows (Figure 1). When coatings were sprayed, heated, and dried in the workplace, nanosilica and
nanosilicates in these coatings aired in the workplace as ﬂocculi (condensation of the aerosol, containing
nanosilica and nanosilicates from the volatilized material) and caused itching on the faces and arms of
patients (dermal toxicity), while the workers used no personal protective equipment (PPE), because the
nanomaterials were invisible and they knew nothing of the toxicity of the materials they were handling.
When inhaled into the pulmonary respiratory tract, the nanomaterials deposited in the pulmonary alveoli
were taken up by macrophages, crossed the lung epithelium, and entered the pulmonary interstitial tissue,
blood, and lymph, ﬁnally reaching extrapulmonary organs of patients, as has been observed in animal
experiments [14], and resulted in the haematotoxicity, hepatotoxicity, cardiotoxicity, and pulmonary and
pleural injuries seen in these patients. The nanomaterials within pleural effusions may have come from
visceral pleura through the pulmonary circulation and from partial pleura through the systemic circulation,
or come from penetration through lung tissue to the pleural membrane, as small-sized nanomaterials like
nanosilica can readily pass through lung tissue or behave like gases [19]. Finally, chronic and repetitive
exposure (5–13 months) to the nanomaterials may have resulted in these patients’ illness and death.
In our patients, the initial and persistent symptoms were the recurring production of copious amounts
of chest ﬂuids. The likelihood of patients developing pleural effusion is a combined effect of nanosilicates
and nanosilica, which can be obtained as an indication from the pleural effusions caused by silicosis or
asbestosis[20]. The occurrenceof pleural effusion may have been causednot by the chemical compositions
1824TheScientiﬁcWorldJOURNAL (2011) 11, 1821–1828
Silica nanoparticles
Polyacrylic ester
Solvents (acetic acid, toluene
and heated
Resp. tract
Face and arms Lung
?
Lymphatics
?
Pleural membrane
Pulmonary and pleural toxicity
Two workers dead and ﬁve disabled
Nanocoating
Sprayed
Heart Liver Other organs
Dermal toxicity Cardiotoxicity Hepatotoxicity Haematotoxicity ??
Blood
, etc.)
Nano- and mircoscale silicates 
FIGURE 1: Potential translocation pathways of nanoparticles and the potential damage. Nanosilica and
nanosilicates in the coatings may air in the workplace when sprayed, heated, and dried, then they deposit in
the pulmonary alveoli when inhaled into the pulmonary respiratory tract, be taken up by macrophages, cross
the lung epithelium, enter the pulmonary interstitial tissue, blood, and lymph, ﬁnally reach extrapulmonary
organs, and result in multiorgan toxicities.
of the nanomaterials but by their nanosize. These nanomaterials are small enough to pass through the lung
tissue into the pleural cavity but large enough to block proper lymphatic drainage of the pleural membrane.
Furthermore, lymphatic ﬂow under physiological conditions amounts to 3µL/min/mm2 and ﬂow velocity
in initial lymphatics is on the order of 2mm/min [21], which is much slower than blood ﬂow velocity and
thus prone to pleural lymphatic stomata blocking. Importantly, the draining role of parietal lymphatics in
patients with asbestosis is demonstrated by the ﬁnding of the “black spots,” the accumulation of asbestos
ﬁbers around the parietal pleural lymphatic stomata due to the ﬁbers being ﬂow-driven towards the pleural
ﬂuid draining sites [22, 23]. Also, the presumption that pleural effusions in our patients may have been
caused by nanomaterials blocking proper lymphatic drainage of the pleural cavity was conﬁrmed by the
observation of lymphangiectasis and lymphostasis in high-resolution CT scans of lungs and pathologic
observation of lungs and pleural membranes.
7. NEW HEALTH AND SAFETY CONCERNS
Our ﬁndings of nanosilica in patients’ biopsies and pleural effusions, together with our previous report, pre-
sent a clue that these silica nanoparticles may have contributed in part to the illness reported in these work-
ers. The reported disease was characterized by bilateral chest ﬂuid, pulmonary ﬁbrosis, and pleural damage
and was featured by a concealed onset (a relatively long latency between initial exposure and disease emer-
gence), rapid and progressive development, and multiorgan damage. These characteristics varied greatly
from diseases such as silicosis or asbestosis which were caused by microscale silica or silicates. Thus,
the disease related to nanomaterials produces new challenges and concerns in terms of how to prevent the
potential risks of nanomaterial exposure to workers and the environment as nanomaterials are invisible.
1825TheScientiﬁcWorldJOURNAL (2011) 11, 1821–1828
(1) This study highlights the urgent needfor safety practice guideline to protect workers. Protocols or
solutions may include regulations for occupational health and safety (OHS) in nanoﬁeld work or
research, medical prescreening and surveillance, establishing industrial hygiene guidelines, and
effective PPE or application of appropriate safeguards. In reality, conventional OHS practices
when handling nanomaterials are usually employed, but the effectiveness of the application of
these classical tools is in doubt. For example, a traditional cotton mask usually has apertures
100–300µm in diameter, much larger than nanoscale, implying that using a cotton mask to avoid
nanomaterial exposure would be ineffective.
(2) A complete assessment of the potential risks and impacts of nanomaterials and nanoproducts on
human health and the environment is essential before they enter commercial markets. Over 1900
different types of nanomaterials have been designed and fabricated, each of which having dis-
tinct physicochemical features, but only dozens of these materials have been studied so far, and
there is little data regarding human toxicity. Additionally, novel, engineered nanomaterials will
increasingly be produced to maximize beneﬁcial physicochemical features, and, concurrently,
more and more nanomaterials will be discarded at the end of their useful life. Hence, human ex-
posure is already occurring and will increase dramatically in coming years. Full assessment of
the potential risks of nanomaterials is essential to avoid future horrible scenarios as studied here.
Nanomaterials should be considered hazardous until proven otherwise.
(3) Nanomaterials in products should be clearly stated or labeled. On the one hand, nanomaterial
manufacturers do not claim what is in their products. On the other hand, the merchants use the
concept of “nano” for marketing. Actually, in our opinion, the injury or suspected injury related
to nanomaterials are observed among consumers than workers, as consumers are not aware of the
risk of the products they are exposed to.
(4) Given the severity of disease related to some nanomaterials, such as nanosilica and nanosilicates
and the great difﬁculties in diagnosis and treatment, it is a new challenge for our clinical doctors.
Much more work including clinical laboratory studies of nanotoxicology is required to prevent,
diagnose, and treat disease or injury related to nanomaterials.
(5) A multidisciplinary collaborative approach, involving at least physicians, material scientists, epi-
demiologists, and toxicologists, should be followed to probe into the association and detailed
mechanisms of nanomaterials with cardiovascular disease, respiratory disease (e.g., asthma,
chronic inﬂammation, and cancer), and mortality as well as immunologic diseases.
(6) Supervisionofthe usageofnanomaterials,whichareeasilyavailable,invisible,andpossiblyhigh-
lytoxic,asseeninourpatients,shouldbeimposedtopreventtheoccurrenceofasimilaraccidental
disaster and also to prevent the potential use of these materials as new weapons by criminals and
terrorists.
(7) More research and collaborative efforts, especially on particular materials, such as the nanosilica
and nanosilicates found in our patients’ biopsies, are required to gain a broad and speciﬁc under-
standing of the distribution, biokinetics, and toxicity of these materials in the human body. Also,
more government funding and private investment in nanotoxicology are essential to provide the
resources to allow extensive understanding of the effects of nanomaterials and nanowaste on hu-
mans and the environment.
(8) Ecotoxicological study to assess the potential entry, hazard, and risk of nanomaterials to the eco-
systemfortheirsaferuseandhandlinghasaccordinglybeenthetopicofgreatinterestandurgency.
In conclusion, our studies show that some kinds of nanomaterials, such as silica nanoparticles and
nanosilicates,may be very toxic and evenfatal to occupationalworkers exposedto but without anyeffective
PPE.And the diseaserelated to thesenanomaterialsproducesnewhealthandsafetyconcernson howto pre-
ventthepotentialrisks ofnanomaterialexposureto workersandtheenvironmentaswell ashowto clinically
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diagnose and treat the disease or injury. More research and collaborative efforts on nanosafety, and more
governmentfundingandprivateinvestmentin nanotoxicologyare requiredin orderto preventandminimize
the potential hazards of nanomaterials to humans and the environment.
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